Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications cardiovascular risk factors disease among non european immigrants living catalonia
Lola Xiao Health Economics Telecommuter - USA MSc, Health Finance and Management Johns Hopkins Bloomberg School of Public Health, Baltimore, DE BS, Business and Finance New York University, Shanghai, China Lola (Ziyi) Xiao, MHS, is a Health Outcomes …
… Therapeutic Experience Explore our Projects, Publications, and Researchers by Therapeutic Area To help …
… best practices are utilized in data protection for non-interventional research, and assisting with business …
… covering 2 annual preventative oral health visits for low-risk adults aged 18 to 64. She has experience building Markov …
… as business intelligence in hospital systems, authoring publications and presenting at conferences on both topics. … leverage and expand his technical and domain experience in disease modeling, cost-effectiveness analysis and …
… real-world data studies in pediatric neurodegenerative disease, and prenatal care and chronic pain program …
FDA’s Sentinel Initiative Driving Sound Research Practices for COVID-19 Vaccine Development Share on: November 11, 2021 RTI-HS is collaborating with the FDA to ensure that rigorous, valid methods are used to evaluate COVID-19 vaccine effectiveness in the …
Forbes Magazine Recognizes RTI International as One of the Best Employers for Diversity Share on: April 26, 2024 The 2024 America’s Best Employers for Diversity rankings resulted from surveying 170,000 US employees RESEARCH TRIANGLE PARK, N.C. — …
Valerie Williams Patient-Centered Outcomes Assessment Women's Health Psychiatry Gastroenterology Headquarters - Research Triangle Park, North Carolina, USA PhD, Quantitative Psychology BA, Psychology University of North Carolina at Chapel Hill, Chapel …
… for those who wish to leverage evidence generation in rare disease research to support communications to healthcare … Who can benefit from early market access planning for rare disease therapies? Companies developing diagnostics or …